Axsome Therapeutics to Participate in Upcoming Investor Conferences
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming i
(Financial Post, 2025-10-22T11:01:31Z)